Pulmonary drug toxicity: FDG-PET findings in patients with lymphoma

[1] Kostakoglu L.(2003)18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma J Nucl Med 44 224-239

[2] Goldsmith S.J.(2005)FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls Radiographics 25 191-207

[3] Kazama T.(2005)18F-FDG PET in malignant lymphoma: significance of positive findings Eur J Nucl Med Mol Imaging 32 749-756

[4] Faria S.C.(2001)18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin’s lymphoma Ann Oncol 12 29-37

[5] Varavithya V.(2001)Bleomycin-induced pneumonitis Chest 120 617-624

[6] Phongkitkarun S.(2000)Pulmonary drug toxicity: radiologic and pathologic manifestations Radiographics 20 1245-1259

[7] Ito H.(2003)Limitations of PET for imaging lymphoma Eur J Nucl Med Mol Imaging 30 S117-S127

[8] Macapinlac H.A.(2002)Bleomycin-induced alveolitis detected by FDG positron emission tomography Clin Nucl Med 27 522-523

[9] Castellucci P.(2006)FDG positron emission tomography/computerized tomography features of bleomycin-induced pneumonitis J Thorac Imaging 21 228-230

[10] Zinzani P.L.(1998)Prospective investigation of positron emission tomography in lung nodules J Clin Oncol 16 1075-1084

[1] Kostakoglu L.(2003)18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma J Nucl Med 44 224-239

[2] Goldsmith S.J.(2005)FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls Radiographics 25 191-207

[3] Kazama T.(2005)18F-FDG PET in malignant lymphoma: significance of positive findings Eur J Nucl Med Mol Imaging 32 749-756

[4] Faria S.C.(2001)18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin’s lymphoma Ann Oncol 12 29-37

[5] Varavithya V.(2001)Bleomycin-induced pneumonitis Chest 120 617-624

[6] Phongkitkarun S.(2000)Pulmonary drug toxicity: radiologic and pathologic manifestations Radiographics 20 1245-1259

[7] Ito H.(2003)Limitations of PET for imaging lymphoma Eur J Nucl Med Mol Imaging 30 S117-S127

[8] Macapinlac H.A.(2002)Bleomycin-induced alveolitis detected by FDG positron emission tomography Clin Nucl Med 27 522-523

[9] Castellucci P.(2006)FDG positron emission tomography/computerized tomography features of bleomycin-induced pneumonitis J Thorac Imaging 21 228-230

[10] Zinzani P.L.(1998)Prospective investigation of positron emission tomography in lung nodules J Clin Oncol 16 1075-1084